Sparganium (Bur-reed) is a genus of flowering plants, which contains about 20 species in temperate regions of both the Northern and Southern Hemispheres. Three Sparganium species, S. stoloniferum, S. angustifolium, and S. japonicum, grow in Korea. S. stoloniferum is widely distributed in the wet valley areas, and has been used as an emmenagogue, a galactogogue, and an antispasmodic agent in Chinese folk medicine, 1,2 and also for the treatment of menstrual disorders and chronic hepatitis. 3 Previous phytochemical investigations on this plant reported the isolation of pyrrole carboxylic acid ester, 4 phenylpropanoid glycosides, [5] [6] [7] and two sucrose esters. 8 Aldose reductase inhibition, 9 anti-inflammatory, and anti-thrombotic 10 activities of an EtOH extract have also been reported. In our continuing study on the constituents of Korean medicinal plant sources, we have identified molecules from the rhizome of S. stoloniferum. Column chromatograpic purification of the MeOH extract of the rhizome of this source led to isolation of two new constituents (1-2), together with three known compounds (3) (4) (5) . The structures of the new compounds (1-2) were determined through spectral analysis, and chemical means. The isolated compounds (1) (2) (3) (4) (5) were tested for cytotoxicity against four human tumor cells in vitro using a sulforhodamin B (SRB) bioassay.
Compound 1 was isolated as a colorless gum, +4.0°( 
H-

1
H COSY correlations between the methine proton signal at δ H 5.60 (t, J = 7.0 Hz, H-2), and the methylene proton signals at δ H 3.02 (m, H-3) were observed. The HMBC correlations between the methoxy group at δ H 3.78 (OCH 3 -4) and the carbonyl carbon at δ C 170.1 (C-4) and the other methoxy group at δ H 3.73 (OCH 3 -1) and carbonyl carbon at δ C 170.4 (C-1) implied that two methoxy groups were present at C-1 and C-4. These data indicated the presence of a 1,4-dimethyl malate group.
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The HMBC spectrum showed that the methine proton at 5.60 (1H, t, J = 7.0 Hz, H-2) correlated with the carbonyl carbon at δ C 160.1 (C-6') ( H-NMR and MS spectra.
12 The 1,4-dimethyl malate with S configuration at C-2 was reported to show a positive optical rotation ( +20.4, CHCl 3 ).
13
The optical rotation of 1a exhibited a positive value ([á] D +27.5, CHCl 3 ), indicating that the absolute configuration at C-2 in 1a was to be the S form. Thus, compound 1 was determined to be ( C-NMR spectrum, which suggested the presence of Dglucopyranose unit. 15 The coupling constant (J = 7.5 Hz) of the anomeric proton of D-glucose indicated to be in the β-form. 15 Additionally, 1 H, and
C-NMR spectra showed signals for a 3-hydroxy-3-methylglutaryl group (HMG) 16 ; a tert-methyl at δ H 1.29 (3H, s, H-6"), and δ C 26.6 (C-6"), two methylenes at δ H 2.57 (2H, s, H-2"), and δ C 46.1 (C-2"); 2.50 (1H, d, J = 15.5 Hz, H-4"a), and 2.34 (1H, d, J = 15.5 Hz, H-4"b), δ C 46.8 (C-4"), and three quaternary carbons at δ C 178.5 (C-5"), 171.5 (C-1"), and 69.7 (C-3"). The glucose position was established by an HMBC experiment, in which a long-range correlation was observed between the δ H 4.38 (H-1) of D-glucose and the δ C 139.5 (C-1) of the 1,3,4-trisubstituted aromatic ring. Also the location of HMG group was determined by correlations between δ H 4.44, 4.20 (H-6') of the D-glucose moiety and δ C 171.5 (C-1"), in the HMBC spectrum (Fig. 2) . Alkaline methanolysis (1% NaOMe in MeOH) of 2 afforded 3-hydroxy-3-methylglutarate (2a), which was identified by the comparison of its optical rotation value, as well as 1 H-NMR and MS spectra. 17 The glucose was identified with authentic samples (Aldrich Co.) using silica gel co-TLC (CHCl 3 :MeOH;H 2 O = 9:4:0.5, R f 0.30), and optical rotation value { +49.5, (c 0.02, H 2 O)}. The 3-hydroxy-3-methylglutarate with S configuration at C-3" was reported to show a positive optical rotation (  +8.3, CHCl 3 ) . 17 The optical rotation of 2a exhibited a positive value ( +17.1, CHCl 3 ), indicating that the absolute configuration of the asymmetric carbon at C-3" of the HMG moiety was determined to be S form. Thus, the structure of 2 was determined to be 3,
Known compounds were identified as dihydrophaseic acid 3-O-β-D-glucopyranoside (3), 18 (+)-lyoniresinol 3α-O-β-Dglucopyranoside (4), 19 and (+)-5,5'-dimethoxy secoisolariciresinol 3α-O-β-D-glucopyranoside (5) 20 by comparison of physicochemical and spectroscopic data with previously reported literature values. Compounds 3-5 were isolated for the first time from this plant.
The cytotoxicities of compounds (1-5) were evaluated against the A549, SK-OV-3, SK-MEL-2, and HCT15 human cancer cell lines in vitro using the Sulforhodamine B (SRB) bioassay. 21 All the compounds showed little cytotoxicity against any tested cell line (IC 50 > 100 μM).
Experimental Section
Plant Materials. Sparganium stoloniferum Buch.-Hamil. was purchased in Yeongchenon, Korea, in September, 2008, and the plant was identified by one of the authors (K.R.L.). A voucher specimen (SKKU 2008-19) was deposited in the herbarium of the School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
Extraction and Isolation. The dried and chopped rhizomes of S. stoloniferum (5 kg) were extracted at room temperature with 80% MeOH and evaporated under reduced pressure to give a residue (280 g), which was dissolved in water (800 mL) and solvent-partitioned, resulting in nhexane (17 g), CH 2 Cl 2 (3 g), EtOAc (4 g), and n-BuOH (30 g). The EtOAc fraction (4 g) was separated over a silica gel column with a solvent system (CHCl 3 :MeOH:H 2 O = 25:3:0.1 -100% MeOH) to give nine fractions (E1-E9). Fraction E1 (10 mg) was separated on a RP-C 18 silica gel column with 100% MeOH and purified with a RP-C 18 prep HPLC (95% MeOH) to yield compound 1 (4 mg, R t = 13 min). The n-BuOH fraction (30 g) was separated over a silica gel column with a solvent system of (CHCl 3 :MeOH:H 2 O = 14:3.7:0.1 -100% MeOH) to give nine fractions (B1-B10). Fraction B4 (400 mg) was separated over a RP-C 18 Lobar A ® -column with a solvent system of 40% MeOH to give two subfractions (B41-B42). Subfraction B41 (15 mg) was purified with a RP-C 18 prep HPLC (50% MeOH) to yield compound 5 (5 mg, R t = 15 min). Fraction B7 (590 mg) was subjected to Sephadex LH-20 column chromatography eluted with 100% MeOH as to give seven subfractions (B71-B77). Subfraction B72 (34 mg) was purified with a silica gel prep HPLC (CH 3 Cl:MeOH = 2:1) to yield compound 3 (4 mg, R t = 16 min). Subfraction B76 (30 mg) was purified with a RP-C 18 prep HPLC (50% MeOH) to yield compound 2 (5 mg, R t = 13 min). Subfraction B77 (19 mg) was purified with a RP-C 18 prep HPLC (50% MeOH) to yield compound 4 (5 mg, R t = 17 min). Alkaline Hydrolysis of Compound 1. Compound 1 (1.7 mg) was hydrolyzed with 0.1 M KOH (1 mL) at room temperature for 3 h. Then H 2 O (3 mL) was added and the mixture was extracted with CHCl 3 three times, and the CHCl 3 extract was evaporated in vacuo. The CHCl 3 extract was purified over a silica gel Waters Sep-Pak Vac 6cc (CHCl 3 :MeOH = 10:1) to give 1a, which was identified by 
